טוען...
Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis
The use of immunobiological agents for the treatment of autoimmune diseases is increasing in medical practice. Anti-TNF therapies have been increasingly used in refractory autoimmune diseases, especially rheumatoid arthritis, with promising results. However, the use of such therapies has been associ...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Sociedade Brasileira de Pneumologia e Tisiologia
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4075924/ https://ncbi.nlm.nih.gov/pubmed/24626274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1806-37132014000100012 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|